GlassScriptPhysician profile
Leah Rose Farley
NPI 1114665866
$921.47
in general payments reported to CMS, 2019-2025
18 companies · $330 in 2025
The $330 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $107 · 2024: $484 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $149.83 | 2024-2025 | Voquezna |
| Lilly USA, LLC | $111.10 | 2024-2025 | Zepbound, Mounjaro, Kisunla |
| Novo Nordisk INC | $109.35 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Lundbeck LLC | $90.21 | 2024-2025 | Rexulti, Vyepti |
| Otsuka America Pharmaceutical, INC. | $74.51 | 2023-2024 | Rexulti, Abilify Maintena |
| Abbvie INC. | $72.81 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $67.74 | 2023-2025 | Breztri |
| Eisai INC. | $58.52 | 2025 | |
| Exact Sciences Corporation | $30.10 | 2024 | Cologuard Collection Kit |
| Ucb, INC. | $25.79 | 2025 | Nayzilam |
| Janssen Biotech, INC. | $23.16 | 2025 | |
| Janssen Pharmaceuticals, INC | $19.65 | 2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $17.00 | 2024 | |
| Neurelis, INC. | $14.96 | 2025 | Valtoco |
| Pfizer INC. | $14.42 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $14.30 | 2024 | Shingrix, Arexvy, Bexsero |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.09 | 2023 | Tradjenta, Jardiance |
| Aimmune Therapeutics, INC. | $13.93 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Farley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.